Analysis
Acquirers have spent at least $119.8 billion buying US startups so far in 2026, putting the year on pace to exceed 2025's record-setting tally, according to Crunchbase News. The catalyst-in-chief is SpaceX's $60 billion acquisition of Cursor and its parent Anysphere -- the largest startup purchase ever, nearly double the previous record, which SpaceX consummated after its IPO this month using an option it took out in April.
The context reframes the deal. Before Cursor, the biggest startup acquisition on record was Google's $32 billion purchase of cloud-security firm Wiz, followed by Facebook's $19 billion WhatsApp deal in 2014. Cursor at $60 billion doesn't just break the record -- it laps it, and it demonstrates how an IPO transforms a company into an acquirer: SpaceX is spending freshly liquid public stock, the same playbook that turned Google and Meta into serial dealmakers.
“Biotech accounted for half of 2026's top-10 deals, including Eli Lilly's acquisition of Kelonia Therapeutics for up to $7 billion -- the largest biotech buyout in years.”
Crucially, the M&A surge isn't an AI-only story. Biotech accounted for half of 2026's top-10 deals, including Eli Lilly's acquisition of Kelonia Therapeutics for up to $7 billion -- the largest biotech buyout in years. Other marquee transactions include Capital One acquiring fintech Brex for $5.15 billion and Qualcomm buying AI-chip startup Modular for $4 billion. The breadth signals that the exit market has thawed across sectors, not just for the AI darlings.
For venture, this is the liquidity story that matters. After years of a frozen exit environment that left LPs starved for distributions and funds unable to recycle capital, a record M&A year -- alongside a reopening IPO window featuring SpaceX, and OpenAI and Anthropic in the wings -- finally puts cash back into the ecosystem. Strategic acquirers paying public-comparable prices for category leaders is exactly the signal founders and GPs have been waiting for.
The bear case: a record dollar figure driven by a single $60 billion outlier can mask thinner activity beneath the headline, and M&A booms can cool fast if public markets wobble or antitrust posture shifts. What to watch: whether deal volume (not just value) sustains through the second half, how regulators treat the largest transactions, and whether the newly public AI winners keep using their stock to buy.
